Description: Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Home Page: www.daxor.com
109 Meco Lane
Oak Ridge,
TN
37830
United States
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Jonathan Adam Feldschuh | Chief Scientific Officer & Director |
| Mr. Michael Richard Feldschuh | Chairman, President & CEO |
| Mr. Robert J. Michel CPA, CPA, M.B.A. | CFO, Chief Compliance Officer & Corporate Secretary |
| Ms. Linda Cooper | Vice President of Development & Operations |
| Ms. Kathryn A. Kornafel | Senior VP of Marketing & Commercial Development |
| Mr. Guido Manzo | Vice President of Sales |
| Ms. Jean Oertel | Senior Vice President Commercialization & Customer Experience |
| Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. | Chief Medical Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.6364 |
| Price-to-Book MRQ: | 1.3179 |
| Price-to-Sales TTM: | 271.2627 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |